MSD's TROP2-targeting antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT), licensed from China's Kelun-Biotech, has improved survival in a late-stage endometrial cancer trial. The positive ...
MSD in the Philippines’ Run Against Cervical Cancer (RACC) has been recognized at the 61st Anvil Awards, earning a Silver Anvil under the PR Tools – Special Events and Exhibits category, for ...
Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic ...
HELSINKI--(BUSINESS WIRE)--TILT Biotherapeutics, a clinical-stage biotechnology company developing cancer immunotherapies, announces it has signed a second clinical trial collaboration and supply ...
Korea approves Keytruda SC, slashing treatment time to 2 minutes Alteogens ALT-B4 enables faster subcutaneous Keytruda launch ...
ST. HELIER, Jersey--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, ...
MSD India launched a cervical cancer awareness campaign with Madhuri Dixit Nene to encourage women and parents to discuss cervical cancer prevention and healthcare options with doctors.
New Delhi, May 6 (PTI) US-based pharma major MSD on Wednesday announced it has roped in Bollywood actor Madhuri Dixit for its country-wide cervical cancer awareness programme in India. The campaign ...
MSD in the Philippines wins a Silver Anvil at the 61st Anvil Awards for Run Against Cervical Cancer. MSD Philippines President and Managing Director Andreas Riedel and Country Medical Lead Dr. Mary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results